Urogen Pharma (URGN) Surges 9.7%: Is This an Indication of Further Gains?
UroGen Pharma(URGN) ZACKS·2024-06-17 18:01
公司股价表现 - Urogen Pharma (URGN) 股价在最近的交易中上涨了9.7%,收于0.88,同比增长14.6% [3] - 预计营收将达到12.41,过去一个月下跌了18.3% [6] - Regenxbio的共识EPS估计在过去一个月上调了0.9%,达到-$1.27,同比增长23.5% [7] - Regenxbio也持有Zacks评级3(持有)[7]